A total of 3 institutions have reported a stake in Lineage Cell Therapeutics, Inc. (NYSE:LCTX) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 30 Sep, 2025 | 49,560,992 | 0 | 0.00% | $83,758,076.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 9,006,930 | 524,057 | 6.18% | $15,221,712.00 |
| RAFFLES ASSOCIATES LP | 30 Sep, 2025 | 5,387,788 | -4,300 | -0.08% | $9,105,362.00 |
| COMERICA BANK | 30 Sep, 2025 | 4,600,000 | 0 | 0.00% | $7,774,000.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 2,680,003 | 79,426 | 3.05% | $4,529,205.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,419,766 | -11,853 | -0.49% | $4,091,534.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 2,230,756 | -29,992 | -1.33% | $3,769,978.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 1,905,633 | -66,702 | -3.38% | $3,220,520.00 |
| Dauntless Investment Group, LLC | 30 Sep, 2025 | 1,614,100 | 408,170 | 33.85% | $2,727,829.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 1,006,451 | 168,988 | 20.18% | $1,700,902.00 |
| STATE STREET CORP | 30 Sep, 2025 | 955,622 | 106,100 | 12.49% | $1,615,001.00 |
| GSA CAPITAL PARTNERS LLP | 30 Sep, 2025 | 670,856 | -226,755 | -25.26% | $1,134.00 |
| RED CRANE WEALTH MANAGEMENT, LLC | 30 Sep, 2025 | 511,363 | 15,365 | 3.10% | $864,203.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 443,352 | -67,110 | -13.15% | $749,264.00 |
| Informed Momentum Co LLC | 30 Sep, 2025 | 442,221 | 442,221 | 0.00% | $747,353.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 354,347 | 36,370 | 11.44% | $598,846.00 |
| ROYAL BANK OF CANADA | 30 Sep, 2025 | 306,272 | 46,324 | 17.82% | $517,000.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 233,436 | 130,124 | 125.95% | $394,507.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 221,000 | 71,000 | 47.33% | $373,490.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 218,274 | 149,999 | 219.70% | $368,883.00 |